Sartorius Stedim Biotech SA Working Capital to Net Assets Ratio
Sartorius Stedim Biotech SA working capital to net assets ratio. Sartorius Stedim Biotech SA (DIM) has a Working Capital to Net Assets ratio of 4.4% as of June 2026. Working capital of €186.30 Million (current assets of €1.35 Billion minus current liabilities of €1.17 Billion) is measured against net assets of €4.25 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sartorius Stedim Biotech SA (2005–2025)
Working capital to net assets ratio of Sartorius Stedim Biotech SA from 2005 to 2025. This chart shows how Sartorius Stedim Biotech SA's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 4.4%, reflecting working capital of €186.30 Million against net assets of €4.25 Billion EUR. Explore investment intensity of Sartorius Stedim Biotech SA to see how much of total assets are deployed in long-term investments.
Sartorius Stedim Biotech SA Working Capital to Net Assets Ratio by Year (2005–2025)
Sartorius Stedim Biotech SA working capital to net assets ratio by year from 2005 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Sartorius Stedim Biotech SA from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see DIM asset base.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.7% | €29.10 Million | €4.13 Billion | €1.44 Billion | €1.41 Billion | ▼ -19.2 pp |
| 2024 | 19.9% | €802.20 Million | €4.02 Billion | €1.74 Billion | €938.80 Million | ▲ +2.1 pp |
| 2023 | 17.9% | €477.80 Million | €2.67 Billion | €1.42 Billion | €937.30 Million | ▼ -7.4 pp |
| 2022 | 25.3% | €635.30 Million | €2.51 Billion | €1.67 Billion | €1.04 Billion | ▲ +1.1 pp |
| 2021 | 24.1% | €418.51 Million | €1.73 Billion | €1.46 Billion | €1.04 Billion | ▲ +3.4 pp |
| 2020 | 20.7% | €307.52 Million | €1.48 Billion | €875.22 Million | €567.69 Million | ▲ +3.2 pp |
| 2019 | 17.5% | €206.46 Million | €1.18 Billion | €633.80 Million | €427.35 Million | ▲ +1.2 pp |
| 2018 | 16.3% | €170.55 Million | €1.04 Billion | €552.53 Million | €381.98 Million | ▲ +0.4 pp |
| 2017 | 16.0% | €140.40 Million | €879.45 Million | €490.85 Million | €350.44 Million | ▼ -3.3 pp |
| 2016 | 19.3% | €147.37 Million | €763.56 Million | €431.73 Million | €284.36 Million | ▲ +7.2 pp |
| 2015 | 12.1% | €78.14 Million | €647.22 Million | €350.83 Million | €272.69 Million | ▲ +3.4 pp |
| 2014 | 8.7% | €46.58 Million | €538.51 Million | €276.17 Million | €229.58 Million | ▼ -13.0 pp |
| 2013 | 21.6% | €104.12 Million | €481.84 Million | €258.51 Million | €154.38 Million | ▲ +22.7 pp |
| 2012 | -1.1% | €-4.62 Million | €434.72 Million | €225.84 Million | €230.46 Million | ▼ -14.2 pp |
| 2011 | 13.1% | €51.95 Million | €395.63 Million | €220.15 Million | €168.20 Million | ▲ +4.5 pp |
| 2010 | 8.6% | €31.46 Million | €365.07 Million | €176.37 Million | €144.91 Million | ▼ -8.1 pp |
| 2009 | 16.8% | €65.88 Million | €393.20 Million | €185.57 Million | €119.69 Million | ▼ -0.8 pp |
| 2008 | 17.5% | €65.10 Million | €371.65 Million | €163.21 Million | €98.11 Million | ▲ +34.2 pp |
| 2007 | -16.7% | €-60.55 Million | €362.76 Million | €161.71 Million | €222.26 Million | ▼ -65.1 pp |
| 2006 | 48.4% | €81.71 Million | €168.93 Million | €202.07 Million | €120.37 Million | ▼ -6.3 pp |
| 2005 | 54.7% | €81.12 Million | €148.35 Million | €192.87 Million | €111.75 Million | — |